Terms: = Ovarian cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
111 results:
1. Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer.
Polen-De C; Giri S; Fadadu P; Weaver A; Mcgree ME; Moynagh M; Takahashi N; Jatoi A; Lebrasseur NK; Cliby W; Williams G; Kumar A
J Natl Cancer Inst Monogr; 2023 May; 2023(61):43-48. PubMed ID: 37139982
[TBL] [Abstract] [Full Text] [Related]
2. The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer.
Kawahara N; Kawaguchi R; Waki K; Maehana T; Yamanaka S; Yamada Y; Kimura F
Sci Rep; 2022 Dec; 12(1):22636. PubMed ID: 36587139
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological Characteristics and prognosis of 91 Patients with Seromucinous and Mucinous Borderline ovarian Tumors: a Comparative Study.
Wu B; Li J; Tao X; Wang J; Zhu G; Lu X; Chen R
Reprod Sci; 2023 Jun; 30(6):1927-1937. PubMed ID: 36512190
[TBL] [Abstract] [Full Text] [Related]
4. Molecular Evidence for Epithelial Origin of Mixed ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
5. Health Care Utilization Prior to ovarian cancer Diagnosis in Publicly Insured Individuals in New York State.
Gates Kuliszewski M; Boscoe FP; Wagner VL; Schymura MJ
J Registry Manag; 2021; 48(3):126-137. PubMed ID: 35413730
[TBL] [Abstract] [Full Text] [Related]
6. Decision-making in postoperative chemotherapy for ovarian metastasis from colorectal cancer: a retrospective single-center study.
Hamasaki S; Fukunaga Y; Nagayama S; Fujimoto Y; Akiyoshi T; Nagasaki T; Ueno M
World J Surg Oncol; 2022 Feb; 20(1):28. PubMed ID: 35105353
[TBL] [Abstract] [Full Text] [Related]
7. Cytoreductive surgery and HIPEC for peritoneal metastasis. Justified hope or desperate illusion? Fifteen years of experience from a Greek Peritoneal Surface Malignancy center.
Spiliotis J; Kopanakis N; Terra A; Iavazzo C; Prodromidou A; Rogdakis A; Efstathiou E
J BUON; 2021; 26(4):1669-1678. PubMed ID: 34565035
[TBL] [Abstract] [Full Text] [Related]
8. Identification of risk factors for the prognosis of Chinese patients with endometrial carcinoma.
Wang N; Zhang J; Fan X; Ma J; He J; Kang S; Cheng J; Ma J
Medicine (Baltimore); 2021 Sep; 100(38):e27305. PubMed ID: 34559145
[TBL] [Abstract] [Full Text] [Related]
9. Secondary Invasive Breast Events among Patients with Hormone-Positive Breast cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and ≥31.
Berger NF; Zimmerman BS; Tharakan S; Suchman K; Cascetta KP; Blanter J; Moshier E; Ru M; Jaffer S; Tiersten A
Oncology; 2021; 99(11):699-702. PubMed ID: 34425579
[TBL] [Abstract] [Full Text] [Related]
10. Long-term survival differences between sevoflurane and propofol use in general anesthesia for gynecologic cancer surgery.
Takeyama E; Miyo M; Matsumoto H; Tatsumi K; Amano E; Hirao M; Shibuya H
J Anesth; 2021 Aug; 35(4):495-504. PubMed ID: 34008073
[TBL] [Abstract] [Full Text] [Related]
11. How to manage synchronous endometrial and ovarian cancer patients?
Shin W; Park SY; Kang S; Lim MC; Seo SS
BMC Cancer; 2021 May; 21(1):489. PubMed ID: 33933018
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of the Prognostic Outcome between High-Grade ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs.
Eoh KJ; Park J; Kim HM; Lee M; Kim YT
Yonsei Med J; 2021 Apr; 62(4):366-369. PubMed ID: 33779091
[TBL] [Abstract] [Full Text] [Related]
13. Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma.
Matsuura T; Otsuka I; Ouchi T; Ouchi E; Asano R; Miyasaka N
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):305-310. PubMed ID: 33678332
[TBL] [Abstract] [Full Text] [Related]
14. Impact of ARTs on oncological outcomes in young breast cancer survivors.
Condorelli M; De Vos M; Lie Fong S; Autin C; Delvigne A; Vanden Meerschaut F; Wyns C; Imbert R; Cheruy C; Bouziotis J; de Azambuja E; Delbaere A; Lambertini M; Demeestere I
Hum Reprod; 2021 Jan; 36(2):381-389. PubMed ID: 33289029
[TBL] [Abstract] [Full Text] [Related]
15. Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma.
Ebata T; Yonemori K; Nishikawa T; Sudo K; Shimomura A; Noguchi E; Fujiwara Y; Kato T; Hasegawa K; Fujiwara K; Tamura K
Oncology; 2020; 98(10):699-705. PubMed ID: 32526764
[TBL] [Abstract] [Full Text] [Related]
16. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
17. [Appendix cancer with Long-Term Survival after Multimodality Therapy-A Case Report].
Kitagawa D; Hu Q; Takada K; Hasegawa H; Kishihara F; Funahashi S; Kitamura M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2560-2561. PubMed ID: 32156998
[TBL] [Abstract] [Full Text] [Related]
18. A clinicopathological study of granulosa cell tumors of the ovary: Can morphology predict prognosis?
Guleria P; Kumar L; Kumar S; Bhatla N; Ray R; Singhal S; Meena J; Mathur SR
Indian J Pathol Microbiol; 2020; 63(1):53-59. PubMed ID: 32031123
[TBL] [Abstract] [Full Text] [Related]
19. Primary appendiceal mucinous neoplasm: Gynecological manifestations, management, and prognosis.
Zhang W; Tan C; Xu M; Wu X
Gynecol Oncol; 2020 Feb; 156(2):357-362. PubMed ID: 31839341
[TBL] [Abstract] [Full Text] [Related]
20. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
[TBL] [Abstract] [Full Text] [Related]
[Next]
